Frankfurt - Delayed Quote EUR

Aurinia Pharmaceuticals Inc. (IKAP.F)

7.06

+0.07

+(0.97%)

At close: April 25 at 9:39:01 PM GMT+2

Revenue vs. Earnings

Revenue 59.87M

Earnings 1.43M

Q1'24

Q2'24

Q3'24

Q4'24

0

20M

40M

60M

Analyst Price Targets

No Analyst Price Targets available for this ticker

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
No. of Analysts	--	--	--	--
Avg. Estimate	0	0	0	0
Low Estimate	0	0	0	0
High Estimate	0	0	0	0
Year Ago EPS	--	--	--	--

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
No. of Analysts	5	5	5	6
Avg. Estimate	61.06M	64.47M	258.58M	313.57M
Low Estimate	59.1M	63.2M	255.8M	290M
High Estimate	62.1M	66.2M	261.1M	394.71M
Year Ago Sales	50.3M	57.19M	235.13M	258.58M
Sales Growth (year/est)	21.38%	12.73%	9.97%	21.27%

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
Current Estimate	0	0	0	0
7 Days Ago	0	0	0	0
30 Days Ago	0	0	0	0
60 Days Ago	0	0	0	0
90 Days Ago	0	0	0	0

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
Up Last 7 Days	--	--	--	--
Up Last 30 Days	--	--	--	--
Down Last 7 Days	--	--	--	--
Down Last 30 Days	--	--	--	--

	Current Qtr.	Next Qtr.	Current Year	Next Year
IKAP.F	--	--	--	--
S&P 500	6.94%	4.52%	8.32%	14.18%

Reiterates	Cantor Fitzgerald: Overweight to Overweight	9/16/2024
Reiterates	Cantor Fitzgerald: Overweight to Overweight	9/9/2024
Reiterates	HC Wainwright & Co.: Buy to Buy	9/6/2024
Reiterates	HC Wainwright & Co.: Buy to Buy	3/1/2024
Maintains	Cantor Fitzgerald: Overweight to Overweight	2/23/2024
Maintains	HC Wainwright & Co.: Buy to Buy	2/22/2024